Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS

https://doi.org/10.20996/1819-6446-2009-5-5-59-62

Full Text:

Abstract

Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus (DM2) in real clinical practice.

Material and methods. 200 patients with DM2, who consented to take part in the questionnaire, were examined. Questionnaire data evaluation and clinical examination was performed as well as plasma levels of glucose, glycosylated hemoglobin (HbA1c) and lipids estimation.

Results. Low rate of diagnosed DM2 complications especially nephropathy was observed. 68% of patients had high level of glycosylated hemoglobin (HbA1c) because of their knowledge lack as well as inadequate glucose self-monitoring or it’s absent and uncommon combined glucose-lowering therapy. Depression was revealed in 43,5% of patients, especially in patients with chronic DM2 complications. Low incidence of depression was associated with good patient knowledge about DM2. Well informed patients had lower score according to CES-D scale than patients with DM2 complications.

Conclusion. Appropriate drug therapy, patients’ education, early depression diagnosis and treatment are necessary to improve glycemic control in DM2 patients.

About the Authors

I. E. Sapozhnikova
Kirov State Medical Academy
Russian Federation

Chair of Hospital Therapy

K.Marxa ul. 112, Kirov, 610027



E. I. Tarlovskaya
Kirov State Medical Academy
Russian Federation

Chair of Hospital Therapy

K.Marxa ul. 112, Kirov, 610027



E. N. Anufrieva
Kirov State Medical Academy
Russian Federation

Chair of Hospital Therapy

K.Marxa ul. 112, Kirov, 610027



A. A. Sobolev
Kirov Regional Endocrinology Clinic
Russian Federation
Semashko ul. 2-A, Kirov, 610030


E. V. Rodygina
Kirov Regional Endocrinology Clinic
Russian Federation
Semashko ul. 2-A, Kirov, 610030


References

1. Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: estimated for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.

2. Дедов И.И., Шестакова М.В. Сахарный диабет. М.: Универсум Паблишинг; 2003.

3. Joslin E.P., Kahn C.R., Weir G.C. et al, editors. Joslin’s Diabetes Mellitus. Philadelphia: Lippincott Williams & Wilkins; 2004. P. 976-977.

4. Rydén L., Standl E., Bartnik M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28(1):88-136.

5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317(7160):703-13.

6. Gaede P., Vedel P., Larsen N. et al. Multifactorial intervention and cardiovascular disaese in patients with type 2 diabetes. N Engl J Med 2003;348(5):383-93

7. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА; 2003.

8. Дробижев М.Ю., Захарчук Т.А. Депрессии у больных сахарным диабетом (обзор литературы). Часть 1. Психиатрия и психофармакотерапия 2006;8(4):68-71.

9. Сапожникова И.Е., Тарловская Е.И., Ануфриева Е.Н. Cardiovascular diseases treatment in patients with type 2 diabetes mellitus in current clinical practice / Терапия сердечно-сосудистых заболеваний у пациентов с сахарным диабетом 2 типа в реальной клинической практике. Рациональная фармакотерапия в кардиологии 2009;(3):7-13

10. Сунцов Ю.И., Дедов И.И., Шестакова М.В. Скрининг осложнений сахарного диабета как метод оценки качества лечебной помощи больным. М.; 2008.

11. Дедов И.И., Шестакова М.В. Сахарный диабет и хроническая болезнь почек. М.: МИА; 2009.

12. Дедов И.И., Анциферов М.Б., Галстян Г.Р. и др. Обучение больных сахарным диабетом. М. 1999.

13. Дробижев М.Ю., Захарчук Т.А. Депрессии у больных сахарным диабетом (обзор литературы). Часть II. Психиатрия и психофармакотерапия 2006;8(4):16-27.

14. De Groot M., Anderson R., Freedland K.E. et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63(4):619–30.

15. Procyshyn R.M., Pande S., Tse G. New-onset diabetes mellitus associated with quetiapine. Can J Psychiatry 2000;45(7):668-9.

16. Polonsky W.H., Dudl J., Peterson M. et al. Depression in type 2 diabetes: links to health care utilization, self-care, and medical markers (abstract). Diabetes 2000; 49 (Suppl. 1):A64.


For citation:


Sapozhnikova I.E., Tarlovskaya E.I., Anufrieva E.N., Sobolev A.A., Rodygina E.V. ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS. Rational Pharmacotherapy in Cardiology. 2009;5(5):59-62. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-5-59-62

Views: 461


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)